Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET

Danalyn Byng,*,1,2 Johanna I Lutter*,1, Margarethe E Wacker,1 Rudolf A Jörres,3 Xiaofei Liu,4 Stefan Karrasch3,5, Holger Schulz,5 Claus Vogelmeier,6 Rolf Holle1, On behalf of the COSYCONET Consortium1Institute of Health Economics and Health Care Management, Helmholtz Zentrum Münche...

Full description

Bibliographic Details
Main Authors: Byng D, Lutter JI, Wacker ME, Jörres RA, Liu X, Karrasch S, Schulz H, Vogelmeier C, Holle R
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/determinants-of-healthcare-utilization-and-costs-in-copd-patients-firs-peer-reviewed-article-COPD
_version_ 1818847875483828224
author Byng D
Lutter JI
Wacker ME
Jörres RA
Liu X
Karrasch S
Schulz H
Vogelmeier C
Holle R
author_facet Byng D
Lutter JI
Wacker ME
Jörres RA
Liu X
Karrasch S
Schulz H
Vogelmeier C
Holle R
author_sort Byng D
collection DOAJ
description Danalyn Byng,*,1,2 Johanna I Lutter*,1, Margarethe E Wacker,1 Rudolf A Jörres,3 Xiaofei Liu,4 Stefan Karrasch3,5, Holger Schulz,5 Claus Vogelmeier,6 Rolf Holle1, On behalf of the COSYCONET Consortium1Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, GmbH – German Research Center for Environmental Health, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, 85764 Neuherberg, Germany; 2Institute for Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-University Munich (LMU), 81377 Munich, Germany; 3Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80336 Munich, Germany; 4Institute for Biostatistics, Hannover Medical School, 30625 Hannover, Germany; 5Institute of Epidemiology, Helmholtz Zentrum München (GmbH) – German Research Center for Environmental Health, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), 85764 Neuherberg, Germany; 6Department of Respiratory Medicine, University of Marburg, University Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, 35043 Marburg, Germany*These authors contributed equally to this workBackground: In light of overall increasing healthcare expenditures, it is mandatory to study determinants of future costs in chronic diseases. This study reports the first longitudinal results on healthcare utilization and associated costs from the German chronic obstructive pulmonary disease (COPD) cohort COSYCONET.Material and methods: Based on self-reported data of 1904 patients with COPD who attended the baseline and 18-month follow-up visits, direct costs were calculated for the 12 months preceding both examinations. Direct costs at follow-up were regressed on baseline disease severity and other co-variables to identify determinants of future costs. Change score models were developed to identify predictors of cost increases over 18 months. As possible predictors, models included GOLD grade, age, sex, education, smoking status, body mass index, comorbidity, years since COPD diagnosis, presence of symptoms, and exacerbation history.Results: Inflation-adjusted mean annual direct costs increased by 5% (n.s., €6,739 to €7,091) between the two visits. Annual future costs were significantly higher in baseline GOLD grades 2, 3, and 4 (factors 1.24, 95%-confidence interval [1.07–1.43], 1.27 [1.09–1.48], 1.57 [1.27–1.93]). A history of moderate or severe exacerbations within 12 months, a comorbidity count >3, and the presence of dyspnea and underweight were significant predictors of cost increase (estimates ranging between + €887 and + €3,679, all p<0.05).Conclusions: Higher GOLD grade, comorbidity burden, dyspnea and moderate or severe exacerbations were determinants of elevated future costs and cost increases in COPD. In addition we identified underweight as independent risk factor for an increase in direct healthcare costs over time.Keywords: direct costs, population-based, healthcare expenditures, outpatient costs, inpatient costs, change score
first_indexed 2024-12-19T06:08:24Z
format Article
id doaj.art-9e3e25608156435f844453a726339c54
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-19T06:08:24Z
publishDate 2019-07-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-9e3e25608156435f844453a726339c542022-12-21T20:33:04ZengDove Medical PressInternational Journal of COPD1178-20052019-07-01Volume 141423143946891Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONETByng DLutter JIWacker MEJörres RALiu XKarrasch SSchulz HVogelmeier CHolle RDanalyn Byng,*,1,2 Johanna I Lutter*,1, Margarethe E Wacker,1 Rudolf A Jörres,3 Xiaofei Liu,4 Stefan Karrasch3,5, Holger Schulz,5 Claus Vogelmeier,6 Rolf Holle1, On behalf of the COSYCONET Consortium1Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, GmbH – German Research Center for Environmental Health, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, 85764 Neuherberg, Germany; 2Institute for Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-University Munich (LMU), 81377 Munich, Germany; 3Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80336 Munich, Germany; 4Institute for Biostatistics, Hannover Medical School, 30625 Hannover, Germany; 5Institute of Epidemiology, Helmholtz Zentrum München (GmbH) – German Research Center for Environmental Health, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), 85764 Neuherberg, Germany; 6Department of Respiratory Medicine, University of Marburg, University Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, 35043 Marburg, Germany*These authors contributed equally to this workBackground: In light of overall increasing healthcare expenditures, it is mandatory to study determinants of future costs in chronic diseases. This study reports the first longitudinal results on healthcare utilization and associated costs from the German chronic obstructive pulmonary disease (COPD) cohort COSYCONET.Material and methods: Based on self-reported data of 1904 patients with COPD who attended the baseline and 18-month follow-up visits, direct costs were calculated for the 12 months preceding both examinations. Direct costs at follow-up were regressed on baseline disease severity and other co-variables to identify determinants of future costs. Change score models were developed to identify predictors of cost increases over 18 months. As possible predictors, models included GOLD grade, age, sex, education, smoking status, body mass index, comorbidity, years since COPD diagnosis, presence of symptoms, and exacerbation history.Results: Inflation-adjusted mean annual direct costs increased by 5% (n.s., €6,739 to €7,091) between the two visits. Annual future costs were significantly higher in baseline GOLD grades 2, 3, and 4 (factors 1.24, 95%-confidence interval [1.07–1.43], 1.27 [1.09–1.48], 1.57 [1.27–1.93]). A history of moderate or severe exacerbations within 12 months, a comorbidity count >3, and the presence of dyspnea and underweight were significant predictors of cost increase (estimates ranging between + €887 and + €3,679, all p<0.05).Conclusions: Higher GOLD grade, comorbidity burden, dyspnea and moderate or severe exacerbations were determinants of elevated future costs and cost increases in COPD. In addition we identified underweight as independent risk factor for an increase in direct healthcare costs over time.Keywords: direct costs, population-based, healthcare expenditures, outpatient costs, inpatient costs, change scorehttps://www.dovepress.com/determinants-of-healthcare-utilization-and-costs-in-copd-patients-firs-peer-reviewed-article-COPDdirect costspopulation-basedhealthcare expendituresoutpatient costsinpatient costschange score.
spellingShingle Byng D
Lutter JI
Wacker ME
Jörres RA
Liu X
Karrasch S
Schulz H
Vogelmeier C
Holle R
Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
International Journal of COPD
direct costs
population-based
healthcare expenditures
outpatient costs
inpatient costs
change score.
title Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
title_full Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
title_fullStr Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
title_full_unstemmed Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
title_short Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
title_sort determinants of healthcare utilization and costs in copd patients first longitudinal results from the german copd cohort cosyconet
topic direct costs
population-based
healthcare expenditures
outpatient costs
inpatient costs
change score.
url https://www.dovepress.com/determinants-of-healthcare-utilization-and-costs-in-copd-patients-firs-peer-reviewed-article-COPD
work_keys_str_mv AT byngd determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet
AT lutterji determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet
AT wackerme determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet
AT jorresra determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet
AT liux determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet
AT karraschs determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet
AT schulzh determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet
AT vogelmeierc determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet
AT holler determinantsofhealthcareutilizationandcostsincopdpatientsfirstlongitudinalresultsfromthegermancopdcohortcosyconet